Skip to main content
Premium Trial:

Request an Annual Quote

Optibrium, Lhasa Ink Software Integration Agreement


Optibrium and Lhasa, vendors of software for compound design, selection, and property prediction, have signed an agreement that allows Lhasa's Derek Nexus platform to be offered as an optional plug-in module for Optibrium's StarDrop software.

Lhasa’s Derek Nexus uses data from published and unpublished sources to identify structure-toxicity relationships and alert scientists to the potential for compounds that cause toxicity. Optibrium’s StarDrop uses a probabilistic scoring approach to redesign select candidate compounds that are likely to succeed in drug discovery projects.

The partners said that chemists and toxicologists can use the combined tools to prioritize drug candidates early in the discovery process and reduce the risk of discovering toxicity during the preclinical and clinical phases of development.

The Derek Nexus module predicts whether a compound will cause toxicity based on more than 40 endpoints, including mutagenicity, hepatotoxicity, and cardiotoxicity, they said. Optibrium's StarDrop can then be used to highlight and redesign the problematic region, they said.

The new StarDrop module won't be available until later this year. The partners have not disclosed when that will be.

Financial details of the collaboration are also not being disclosed.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.